Pharmacopoeia of the People's Republic of China

Last updated

The Pharmacopoeia of the People's Republic of China (PPRC) or the Chinese Pharmacopoeia (ChP), compiled by the Pharmacopoeia Commission of the Ministry of Health of the People's Republic of China, is an official compendium of drugs, covering Traditional Chinese and western medicines, which includes information on the standards of purity, description, test, dosage, precaution, storage, and the strength for each drug.

Contents

It is recognized by the World Health Organization as the official pharmacopoeia of China. [1]

Content

The ChP, as of its tenth (2015) edition, comes in 4 volumes for both the Chinese and the English versions:

  1. Traditional Chinese Medicine, ISBN   978-7-5067-7337-9
  2. Chemical Medicine, ISBN   978-7-5067-7343-0
  3. Biological Preparations, ISBN   978-7-5067-7336-2
  4. General rules and common inactive ingredients, ISBN   978-7-5067-7539-7; new volume

The English version is collectively coded as ISBN   978-7-5067-8929-5. The 2015 ChP requires Good Manufacturing Practices for all ChP-compliant medications and in general uses INN for English names. The Chinese version arranges medicines in ascending stroke order, [2] while the English translations do so in alphabetical order.

History

The 1997 English version consists of two volumes: [3]

  1. Volume 1 (Herbal medicine), 1997, ISBN   7-5025-2062-7
  2. Volume 2 (Western medicine), 1997, ISBN   7-5025-2063-5

The 1997 Chinese version (in simplified Chinese) also consists of two volumes, but the English and Chinese versions are not direct translations of each other, as they are sorted differently as is in the current edition.

A third volume was added in the 2005 version. The English edition ( ISBN   7117069821) describes itself as a "compendium of almost all traditional Chinese medicines and most western medicines and preparations. Information is given for each drug on standards of purity, description, test, dosage, precaution, storage and strength. Key features: A total of 2691 monographs: 992 for traditional Chinese medicines and 1699 for modern western drugs. [4]

"Volume I contains monographs of Chinese material medica and pared slice, vegetable oil/fat and its extract, Chinese traditional patent medicines, single ingredient of Chinese crude drug preparations etc.; Volume II deals with monographs of chemical drugs, antibiotics, biochemical preparations, Radiopharmaceuticals and excipients for pharmaceutical use; Volume III contains biological products."

See also

Related Research Articles

<span class="mw-page-title-main">Asafoetida</span> Indian spice derived from Ferula roots

Asafoetida is the dried latex exuded from the rhizome or tap root of several species of Ferula, perennial herbs of the carrot family. It is produced in Iran, Afghanistan, Central Asia, northern India and Northwest China (Xinjiang). Different regions have different botanical sources.

<span class="mw-page-title-main">Pharmacopoeia</span> Book containing directions for the identification of compound medicines

A pharmacopoeia, pharmacopeia, or pharmacopoea, in its modern technical sense, is a book containing directions for the identification of compound medicines, and published by the authority of a government or a medical or pharmaceutical society.

<span class="mw-page-title-main">Chinese herbology</span> Traditional Chinese herbal therapy

Chinese herbology is the theory of traditional Chinese herbal therapy, which accounts for the majority of treatments in traditional Chinese medicine (TCM). A Nature editorial described TCM as "fraught with pseudoscience", and said that the most obvious reason why it has not delivered many cures is that the majority of its treatments have no logical mechanism of action.

The United States Pharmacopeia (USP) is a pharmacopeia for the United States published annually by the over 200-year old United States Pharmacopeial Convention, a nonprofit organization that owns the trademark and also owns the copyright on the pharmacopeia itself.

The dram is a unit of mass in the avoirdupois system, and both a unit of mass and a unit of volume in the apothecaries' system. It was originally both a coin and a weight in ancient Greece. The unit of volume is more correctly called a fluid dram, fluid drachm, fluidram or fluidrachm.

<i>Bencao Gangmu</i> Chinese herbology book

The Bencao gangmu, known in English as the Compendium of Materia Medica or Great Pharmacopoeia, is an encyclopedic gathering of medicine, natural history, and Chinese herbology compiled and edited by Li Shizhen and published in the late 16th century, during the Ming dynasty. Its first draft was completed in 1578 and printed in Nanjing in 1596. The Compendium lists the materia medica of traditional Chinese medicine known at the time, including plants, animals, and minerals that were believed to have medicinal properties.

<span class="mw-page-title-main">Kampo</span> System of Japanese medicine in Japan

Kampo or Kanpō medicine, often known simply as Kanpō, is the study of traditional Japanese medicine in Japan following its introduction, beginning in the 7th century. It was adapted and modified to suit Japanese culture and traditions. Traditional Japanese medicine uses most of the Chinese methods, including acupuncture, moxibustion, traditional Chinese herbology, and traditional food therapy.

The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom. It is an annually published collection of quality standards for medicinal substances in the UK, which is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

<span class="mw-page-title-main">Red yeast rice</span> Type of bright reddish purple fermented rice

Red yeast rice or red rice koji is a bright reddish purple fermented rice, which acquires its color from being cultivated with the mold Monascus purpureus. Red yeast rice is what is referred to as a kōji in Japanese, meaning "grain or bean overgrown with a mold culture", a food preparation tradition going back to ca. 300 BC.

<i>European Pharmacopoeia</i> Major multinational pharmacopoeia published by the European Union

The European Pharmacopoeia is a major regional pharmacopoeia which provides common quality standards throughout the pharmaceutical industry in Europe to control the quality of medicines, and the substances used to manufacture them. It is a published collection of monographs which describe both the individual and general quality standards for ingredients, dosage forms, and methods of analysis for medicines. These standards apply to medicines for both human and veterinary use.

<i>Martindale: The Complete Drug Reference</i>

Martindale: The Complete Drug Reference is a reference book published by Pharmaceutical Press listing some 6,000 drugs and medicines used throughout the world, including details of over 125,000 proprietary preparations. It also includes almost 700 disease treatment reviews.

Chinese patent medicine are herbal medicines in traditional Chinese medicine (TCM), modernized into a ready-to-use form such as tablets, oral solutions or dry suspensions, as opposed to herbs that require cooking.

Chinese classic herbal formulas are combinations of herbs used in Chinese herbology for supposed greater efficiency in comparison to individual herbs. They are the basic herbal formulas that students of Traditional Chinese medicine learn. Later these students will adapt these classic formulas to match the needs of each patient.

Pharmacy in China involves the activities engaged in the preparation, standardization and dispensing of drugs, and its scope includes the cultivation of plants that are used as drugs, the synthesis of chemical compounds of medicinal value, and the analysis of medicinal agents. Pharmacists in China are responsible for the preparation of the dosage forms of drugs, such as tablets, capsules, and sterile solutions for injection. They compound physicians', dentists', and veterinarians' prescriptions for drugs. Pharmacological activities are also closely related to pharmacy in China.

Shō-saiko-tō (小柴胡湯), also known as minor bupuleurum formula and xiǎocháihútāng (XCHT), is a herbal supplement, believed to enhance liver health. Sho-Saiko-To is a widely used prescription drug in China and is a listed formula in China and Japan as a Kampo medicine. There are currently ongoing clinical trials for Sho-Saiko-To at University of California, San Diego and Memorial Sloan-Kettering Cancer Center. The active ingredients of sho-saiko-to discovered so far include baicalin, baicalein, glycyrrhizin, saikosaponins, ginsenosides, wogonin, and gingerol.

Kanggu Zengsheng Wan is a black pill used in Traditional Chinese medicine to "nourish loins and kidney and strengthen the tendons and bones, activate blood circulation and qi flow, and to relieve pain ". It tastes sweet and slightly astringent.

<span class="mw-page-title-main">Gastrodin</span> Chemical compound

Gastrodin is a chemical compound which is the glucoside of gastrodigenin. It has been isolated from the orchid Gastrodia elata and from the rhizome of Galeola faberi. It can also be produced by biotransformation of 4-hydroxybenzaldehyde by Datura tatula cell cultures.

<span class="mw-page-title-main">Effervescent tablet</span> Tablets to release carbon dioxide in water

Effervescent or carbon tablets are tablets which are designed to dissolve in water and release carbon dioxide. The carbon dioxide is generated by a reaction of a compound containing bicarbonate, such as sodium bicarbonate or magnesium bicarbonate, with an acid such as citric acid or tartaric acid. Both compounds are present in the tablet in powder form and start reacting as soon as they dissolve in water.

Chinese ophthalmology is part of Traditional Chinese medicine (TCM). Diseases of the eyes are treated with Chinese herbs, acupuncture/moxibustion, tuina, Chinese dietary therapy as well as qigong and taijiquan.

Nepidermin, also known as recombinant human epidermal growth factor (rhEGF), is a recombinant form of human epidermal growth factor (EGF) and a cicatrizant. As a recombinant form of EGF, nepidermin is an agonist of the epidermal growth factor receptor (EGFR), and is the first EGFR agonist to be marketed. It was developed by Cuban Center for Genetic Engineering and Biotechnology (CIBG), and has been marketed by Heber Biotech as an intralesional injection for diabetic foot ulcer under the trade name Heberprot-P since 2006. As of 2016, Heberprot-P had been marketed in 23 countries, but remains unavailable in the United States. In 2015, preparations were made to conduct the Phase III trials required for FDA approval, however as of 2023 developments in U.S.-Cuba relations have stymied importation of the drug from Cuba.

References

  1. World Health Organization, Index of Pharmacopoeias, 2004.
  2. "凡例 - 中国药典 (2015)" [Legend - ChP 2015]. db.ouryao.com. Archived from the original on 2018-12-10. Retrieved 10 December 2018. 四部收载通则和药用辅料……《中国药典》的英文名称为Pharmacopoeia of the People's Republic of China;英文简称为Chinese Pharmacopoeia;英文缩写为ChP……
  3. "Conservation OnLine - CoOL".
  4. "Pharmacopoeia of The People's Republic of China 2010".